Consolidated Condensed Statements of Cash Flow - USD ($) $ in Millions	6 Months Ended
	Jul. 03, 2021	Jun. 27, 2020
OPERATING ACTIVITIES
Net earnings	$ 82.8	$ 10.9
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	14.4	15.4
Deferred income taxes	1.2	(13.4)
Stock-based compensation expense	21.6	10.2
Pension and SERP expense	7.0	4.3
Debt Related Commitment Fees and Debt Issuance Costs	0.0	0.2
Environmental and other related costs, net of cash payments	(9.4)	34.2
Other	(1.6)	4.3
Changes in operating assets and liabilities:
Accounts receivable	(103.9)	64.5
Inventories	(89.1)	(41.0)
Other operating assets	10.3	6.3
Accounts payable	94.8	(45.9)
Income taxes payable	1.7	3.5
Other operating liabilities	21.9	(14.5)
Net cash provided by operating activities	51.7	39.0
INVESTING ACTIVITIES
Payments to Acquire Businesses, Net of Cash Acquired	0.0	(5.5)
Additions to property, plant and equipment	(6.7)	(6.6)
Payments to Acquire Equity Method Investments	0.0	3.5
Proceeds from Life Insurance Policy	0.0	25.6
Other	(1.4)	(0.8)
Net cash provided by (used in) investing activities	(8.1)	9.2
FINANCING ACTIVITIES
Repayments of Lines of Credit	0.0	(773.0)
Proceeds from Lines of Credit	0.0	538.0
Cash Received From Borrowings Against Company Owned Life Insurance Policies	0.0	24.5
Proceeds from Issuance of Debt	0.0	471.0
Payments on long-term debt	(5.0)	(5.0)
Payments of Debt Issuance Costs	0.0	6.4
Cash dividends paid	(16.9)	(17.0)
Purchases of common stock for treasury	(26.9)	(21.0)
Payment, Tax Withholding, Share-based Payment Arrangement	(13.1)	(19.9)
Proceeds from the exercise of stock options	12.0	2.1
Contributions from noncontrolling interests	4.8	1.8
Net cash provided by (used in) financing activities	(45.1)	195.1
Effect of foreign exchange rate changes	(0.1)	(1.3)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(1.6)	242.0
Cash and cash equivalents at beginning of the year	347.4	180.6
Cash and cash equivalents at end of the quarter	$ 345.8	$ 422.6